Skip to main content
Erschienen in: Clinical & Experimental Metastasis 8/2011

01.12.2011 | Research Paper

The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis

verfasst von: Ning-Qiang Ma, Li-Li Liu, Jie Min, Jun-Wei Wang, Wei-Feng Jiang, Yan Liu, Yan-Guo Feng, Hai-Chuan Su, Ying-Ming Feng, He-Long Zhang

Erschienen in: Clinical & Experimental Metastasis | Ausgabe 8/2011

Einloggen, um Zugang zu erhalten

Abstract

Bone is the third most common site of cancer metastasis. Over 30 to 40% of lung cancers can develop skeletal metastasis and no effective curative therapy exists in clinic cases. Previously we screened the different expression of proteins between SBC-5 cells and SBC-3 cells by proteomic study methods (MALDI-TOF/TOF-MS) and found that calcineurin (hereafter referred as Cn) overexpresses in SBC-5 which has special priority in metastasis to bone in a multiple-organ metastasis mice model. However the roles of Cn in osteotropism of SCLC remain to be elucidated. At present study, we decrease CnAα expression in SBC-5 by lentiviral vector-mediated RNAi and found that down regulation of CnAα gene expression can decrease the proliferation and colony formation rate, impede the cell cycle progression, reduce the cell migration and invasion, and inhibit cells adhering to bone matrix, but not change the apoptosis rate of SBC-5 in vitro. In vivo down or up regulation of CnAα gene expression can only decrease or increase the bone metastasis rate, but not affect the metastasis rate to the visceral organs. Our research reveals that CnAα is closely related to the osteotropism metastasis of SCLC and a candidate tumor promotor gene for developing bone metastases.
Literatur
1.
Zurück zum Zitat Kingsley LA, Fournier PG, Chirgwin JM et al (2007) Molecular biology of bone metastasis. Mol Cancer Ther 6(10):2609–2617PubMedCrossRef Kingsley LA, Fournier PG, Chirgwin JM et al (2007) Molecular biology of bone metastasis. Mol Cancer Ther 6(10):2609–2617PubMedCrossRef
2.
Zurück zum Zitat Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96PubMedCrossRef Jemal A, Siegel R, Ward E et al (2008) Cancer statistics, 2008. CA Cancer J Clin 58(2):71–96PubMedCrossRef
3.
Zurück zum Zitat Ogino H, Yano S, Kakiuchi S et al (2008) Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin Cancer Res 14(3):660–667PubMedCrossRef Ogino H, Yano S, Kakiuchi S et al (2008) Follistatin suppresses the production of experimental multiple-organ metastasis by small cell lung cancer cells in natural killer cell-depleted SCID mice. Clin Cancer Res 14(3):660–667PubMedCrossRef
4.
Zurück zum Zitat Miki T, Yano S, Hanibuchi M et al (2000) Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol Res 12(5):209–217PubMed Miki T, Yano S, Hanibuchi M et al (2000) Bone metastasis model with multiorgan dissemination of human small-cell lung cancer (SBC-5) cells in natural killer cell-depleted SCID mice. Oncol Res 12(5):209–217PubMed
5.
Zurück zum Zitat McCaffrey PG, Perrino BA, Soderling TR et al (1993) NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem 268(5):3747–3752PubMed McCaffrey PG, Perrino BA, Soderling TR et al (1993) NF-ATp, a T lymphocyte DNA-binding protein that is a target for calcineurin and immunosuppressive drugs. J Biol Chem 268(5):3747–3752PubMed
6.
Zurück zum Zitat Liu J, Farmer JD Jr, Lane WS et al (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66(4):807–815PubMedCrossRef Liu J, Farmer JD Jr, Lane WS et al (1991) Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66(4):807–815PubMedCrossRef
7.
Zurück zum Zitat Buchholz M, Schatz A, Wagner M et al (2006) Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J 25(15):3714–3724PubMedCrossRef Buchholz M, Schatz A, Wagner M et al (2006) Overexpression of c-myc in pancreatic cancer caused by ectopic activation of NFATc1 and the Ca2+/calcineurin signaling pathway. EMBO J 25(15):3714–3724PubMedCrossRef
8.
Zurück zum Zitat Duque J, Fresno M, Iniguez MA (2005) Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 280(10):8686–8693PubMedCrossRef Duque J, Fresno M, Iniguez MA (2005) Expression and function of the nuclear factor of activated T cells in colon carcinoma cells: involvement in the regulation of cyclooxygenase-2. J Biol Chem 280(10):8686–8693PubMedCrossRef
9.
Zurück zum Zitat Aagaard L, Rossi JJ (2007) RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 59(2–3):75–86PubMedCrossRef Aagaard L, Rossi JJ (2007) RNAi therapeutics: principles, prospects and challenges. Adv Drug Deliv Rev 59(2–3):75–86PubMedCrossRef
10.
Zurück zum Zitat Tiscornia G, Singer O, Ikawa M et al (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 100(4):1844–1848PubMedCrossRef Tiscornia G, Singer O, Ikawa M et al (2003) A general method for gene knockdown in mice by using lentiviral vectors expressing small interfering RNA. Proc Natl Acad Sci USA 100(4):1844–1848PubMedCrossRef
11.
Zurück zum Zitat Rubinson DA, Dillon CP, Kwiatkowski AV et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33(3):401–406PubMedCrossRef Rubinson DA, Dillon CP, Kwiatkowski AV et al (2003) A lentivirus-based system to functionally silence genes in primary mammalian cells, stem cells and transgenic mice by RNA interference. Nat Genet 33(3):401–406PubMedCrossRef
12.
Zurück zum Zitat Liu Y, Zhang Y, Min J et al (2010) Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer. Tumour Biol 31(3):199–207PubMedCrossRef Liu Y, Zhang Y, Min J et al (2010) Calcineurin promotes proliferation, migration, and invasion of small cell lung cancer. Tumour Biol 31(3):199–207PubMedCrossRef
13.
Zurück zum Zitat Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494–498PubMedCrossRef Elbashir SM, Harborth J, Lendeckel W et al (2001) Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells. Nature 411(6836):494–498PubMedCrossRef
14.
Zurück zum Zitat Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15(2):188–200PubMedCrossRef Elbashir SM, Lendeckel W, Tuschl T (2001) RNA interference is mediated by 21- and 22-nucleotide RNAs. Genes Dev 15(2):188–200PubMedCrossRef
15.
Zurück zum Zitat Sharp JA, Waltham M, Williams ED et al (2004) Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis 21(1):19–29PubMedCrossRef Sharp JA, Waltham M, Williams ED et al (2004) Transfection of MDA-MB-231 human breast carcinoma cells with bone sialoprotein (BSP) stimulates migration and invasion in vitro and growth of primary and secondary tumors in nude mice. Clin Exp Metastasis 21(1):19–29PubMedCrossRef
16.
Zurück zum Zitat Sung V, Cattell DA, Bueno JM et al (1997) Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay. Clin Exp Metastasis 15(2):173–183PubMedCrossRef Sung V, Cattell DA, Bueno JM et al (1997) Human breast cancer cell metastasis to long bone and soft organs of nude mice: a quantitative assay. Clin Exp Metastasis 15(2):173–183PubMedCrossRef
17.
Zurück zum Zitat Yin JJ, Pollock CB, Kelly K (2005) Mechanisms of cancer metastasis to the bone. Cell Res 15(1):57–62PubMedCrossRef Yin JJ, Pollock CB, Kelly K (2005) Mechanisms of cancer metastasis to the bone. Cell Res 15(1):57–62PubMedCrossRef
18.
Zurück zum Zitat Siclari VA, Guise TA, Chirgwin JM (2006) Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 25(4):621–633PubMedCrossRef Siclari VA, Guise TA, Chirgwin JM (2006) Molecular interactions between breast cancer cells and the bone microenvironment drive skeletal metastases. Cancer Metastasis Rev 25(4):621–633PubMedCrossRef
19.
Zurück zum Zitat Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22(42):6524–6536PubMedCrossRef Bogenrieder T, Herlyn M (2003) Axis of evil: molecular mechanisms of cancer metastasis. Oncogene 22(42):6524–6536PubMedCrossRef
20.
Zurück zum Zitat Roodman GD (2001) Biology of osteoclast activation in cancer. J Clin Oncol 19(15):3562–3571PubMed Roodman GD (2001) Biology of osteoclast activation in cancer. J Clin Oncol 19(15):3562–3571PubMed
21.
Zurück zum Zitat Sone S, Yano S (2007) Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev 26(3–4):685–689PubMedCrossRef Sone S, Yano S (2007) Molecular pathogenesis and its therapeutic modalities of lung cancer metastasis to bone. Cancer Metastasis Rev 26(3–4):685–689PubMedCrossRef
22.
Zurück zum Zitat Uy HL, Mundy GR, Boyce BF et al (1997) Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res 57(15):3194–3199PubMed Uy HL, Mundy GR, Boyce BF et al (1997) Tumor necrosis factor enhances parathyroid hormone-related protein-induced hypercalcemia and bone resorption without inhibiting bone formation in vivo. Cancer Res 57(15):3194–3199PubMed
23.
Zurück zum Zitat Cai Z, Chen Q, Chen J et al (2009) Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia 11(3):228–236PubMed Cai Z, Chen Q, Chen J et al (2009) Monocyte chemotactic protein 1 promotes lung cancer-induced bone resorptive lesions in vivo. Neoplasia 11(3):228–236PubMed
24.
Zurück zum Zitat Han JH, Choi SJ, Kurihara N et al (2001) Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97(11):3349–3353PubMedCrossRef Han JH, Choi SJ, Kurihara N et al (2001) Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 97(11):3349–3353PubMedCrossRef
25.
Zurück zum Zitat Miki T, Yano S, Hanibuchi M et al (2004) Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int J Cancer 108(4):511–515PubMedCrossRef Miki T, Yano S, Hanibuchi M et al (2004) Parathyroid hormone-related protein (PTHrP) is responsible for production of bone metastasis, but not visceral metastasis, by human small cell lung cancer SBC-5 cells in natural killer cell-depleted SCID mice. Int J Cancer 108(4):511–515PubMedCrossRef
26.
Zurück zum Zitat Yamada T, Muguruma H, Yano S et al (2009) Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice. Mol Cancer Ther 8(1):119–126PubMedCrossRef Yamada T, Muguruma H, Yano S et al (2009) Intensification therapy with anti-parathyroid hormone-related protein antibody plus zoledronic acid for bone metastases of small cell lung cancer cells in severe combined immunodeficient mice. Mol Cancer Ther 8(1):119–126PubMedCrossRef
27.
Zurück zum Zitat Flanagan AM, Chambers TJ (1991) Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone. Calcif Tissue Int 49(6):407–415PubMedCrossRef Flanagan AM, Chambers TJ (1991) Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone. Calcif Tissue Int 49(6):407–415PubMedCrossRef
28.
Zurück zum Zitat Muguruma H, Yano S, Kakiuchi S et al (2005) Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin Cancer Res 11(24 Pt 1):8822–8828PubMedCrossRef Muguruma H, Yano S, Kakiuchi S et al (2005) Reveromycin A inhibits osteolytic bone metastasis of small-cell lung cancer cells, SBC-5, through an antiosteoclastic activity. Clin Cancer Res 11(24 Pt 1):8822–8828PubMedCrossRef
29.
Zurück zum Zitat Sugiura R, Sio SO, Shuntoh H et al (2001) Molecular genetic analysis of the calcineurin signaling pathways. Cell Mol Life Sci 58(2):278–288PubMedCrossRef Sugiura R, Sio SO, Shuntoh H et al (2001) Molecular genetic analysis of the calcineurin signaling pathways. Cell Mol Life Sci 58(2):278–288PubMedCrossRef
30.
Zurück zum Zitat Tomono M, Toyoshima K, Ito M et al (1998) Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Arch Biochem Biophys 353(2):374–378PubMedCrossRef Tomono M, Toyoshima K, Ito M et al (1998) Inhibitors of calcineurin block expression of cyclins A and E induced by fibroblast growth factor in Swiss 3T3 fibroblasts. Arch Biochem Biophys 353(2):374–378PubMedCrossRef
31.
Zurück zum Zitat Du MR, Zhou WH, Dong L et al (2008) Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways. Biol Reprod 78(6):1102–1110PubMedCrossRef Du MR, Zhou WH, Dong L et al (2008) Cyclosporin A promotes growth and invasiveness in vitro of human first-trimester trophoblast cells via MAPK3/MAPK1-mediated AP1 and Ca2+/calcineurin/NFAT signaling pathways. Biol Reprod 78(6):1102–1110PubMedCrossRef
32.
Zurück zum Zitat Al-Daraji WI, Grant KR, Ryan K et al (2002) Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol 118(5):779–788PubMedCrossRef Al-Daraji WI, Grant KR, Ryan K et al (2002) Localization of calcineurin/NFAT in human skin and psoriasis and inhibition of calcineurin/NFAT activation in human keratinocytes by cyclosporin A. J Invest Dermatol 118(5):779–788PubMedCrossRef
33.
Zurück zum Zitat Mizunuma M, Hirata D, Miyahara K et al (1998) Role of calcineurin and Mpk1 in regulating the onset of mitosis in budding yeast. Nature 392(6673):303–306PubMedCrossRef Mizunuma M, Hirata D, Miyahara K et al (1998) Role of calcineurin and Mpk1 in regulating the onset of mitosis in budding yeast. Nature 392(6673):303–306PubMedCrossRef
34.
Zurück zum Zitat Masuo T, Okamura S, Zhang Y et al (2009) Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen. Cancer Lett 285(1):66–72PubMedCrossRef Masuo T, Okamura S, Zhang Y et al (2009) Cyclosporine A inhibits colorectal cancer proliferation probably by regulating expression levels of c-Myc, p21(WAF1/CIP1) and proliferating cell nuclear antigen. Cancer Lett 285(1):66–72PubMedCrossRef
35.
Zurück zum Zitat Medyouf H, Alcalde H, Berthier C et al (2007) Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 13(6):736–741PubMedCrossRef Medyouf H, Alcalde H, Berthier C et al (2007) Targeting calcineurin activation as a therapeutic strategy for T-cell acute lymphoblastic leukemia. Nat Med 13(6):736–741PubMedCrossRef
36.
Zurück zum Zitat Iguchi H, Tanaka S, Ozawa Y et al (1996) An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56(17):4040–4043PubMed Iguchi H, Tanaka S, Ozawa Y et al (1996) An experimental model of bone metastasis by human lung cancer cells: the role of parathyroid hormone-related protein in bone metastasis. Cancer Res 56(17):4040–4043PubMed
37.
Zurück zum Zitat Chiriva-Internati M, Grizzi F, Weidanz JA et al (2007) A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. J Immunol Methods 321(1–2):86–93PubMedCrossRef Chiriva-Internati M, Grizzi F, Weidanz JA et al (2007) A NOD/SCID tumor model for human ovarian cancer that allows tracking of tumor progression through the biomarker Sp17. J Immunol Methods 321(1–2):86–93PubMedCrossRef
38.
Zurück zum Zitat Hirotani H, Tuohy NA, Woo JT et al (2004) The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279(14):13984–13992PubMedCrossRef Hirotani H, Tuohy NA, Woo JT et al (2004) The calcineurin/nuclear factor of activated T cells signaling pathway regulates osteoclastogenesis in RAW264.7 cells. J Biol Chem 279(14):13984–13992PubMedCrossRef
39.
Zurück zum Zitat Stern PH (2006) The calcineurin-NFAT pathway and bone: intriguing new findings. Mol Interv 6(4):193–196PubMedCrossRef Stern PH (2006) The calcineurin-NFAT pathway and bone: intriguing new findings. Mol Interv 6(4):193–196PubMedCrossRef
40.
Zurück zum Zitat Ohshiba T, Miyaura C, Inada M et al (2003) Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis. Br J Cancer 88(8):1318–1326PubMedCrossRef Ohshiba T, Miyaura C, Inada M et al (2003) Role of RANKL-induced osteoclast formation and MMP-dependent matrix degradation in bone destruction by breast cancer metastasis. Br J Cancer 88(8):1318–1326PubMedCrossRef
Metadaten
Titel
The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis
verfasst von
Ning-Qiang Ma
Li-Li Liu
Jie Min
Jun-Wei Wang
Wei-Feng Jiang
Yan Liu
Yan-Guo Feng
Hai-Chuan Su
Ying-Ming Feng
He-Long Zhang
Publikationsdatum
01.12.2011
Verlag
Springer Netherlands
Erschienen in
Clinical & Experimental Metastasis / Ausgabe 8/2011
Print ISSN: 0262-0898
Elektronische ISSN: 1573-7276
DOI
https://doi.org/10.1007/s10585-011-9408-6

Weitere Artikel der Ausgabe 8/2011

Clinical & Experimental Metastasis 8/2011 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.